CHAI is pleased to publish the Resource Toolkit on Global Fund to fight AIDS, TB, and Malaria (GFATM) 2023 Funding Opportunity for Hepatitis.
The GFATM policies have evolved to increasingly enable countries to request resources to support viral hepatitis, harm reduction, and triple elimination services. As such, the latest GFATM funding cycle allows countries to prioritize requests for hepatitis services for people living with HIV (PLHIV), key populations such as men who have sex with men, and pregnant women.
CHAI, with support from partners, World Hepatitis Alliance, World Health Organization, The Hepatitis Fund, and others, have developed the toolkit to assist countries to navigate the GFATM application process. Developing a strong proposal for a GFATM grant requires many stakeholders to evaluate and determine country funding priorities and navigate numerous GFATM documents and policies. The Toolkit equips a wide range of stakeholders, including, but not limited to, ministries of health, partners, and civil society, with the intel and tools to understand the GFATM hepatitis-related policies and processes to develop strong proposals.
The Toolkit aims to support advocacy efforts for hepatitis services within this next round of funding requests in 2023. It includes:
- A detailed summary of the evolution of GFATM hepatitis-related policies and specific guidance for the 2023-2025 funding round.
- Several country case studies highlighting countries that have been successful in this process.
- Tools and guidance for advocacy and funding requests such as the rationale for making hepatitis-related investments, ensuring program cost-effectiveness, a summary of pricing for HBV and HCV commodities, a generic advocacy workplan, and a checklist that can be customized to country settings.
As there is limited funding for hepatitis programs, this next GFATM funding round will be a critical opportunity for countries to request GFATM funding to introduce and/or strengthen hepatitis programs, utilizing existing service delivery platforms such as those for HIV, harm reduction, antenatal care, and primary care. Countries interested in leveraging GFATM funding for hepatitis programming must evaluate and define a funding ask appropriate for their context informed by:
- Epidemiology
- Programmatic needs and priorities
- Potential impact and rationale
The request must explain how these investments can improve outcomes for PLHIV, articulate program readiness, and plan for integration and implementation. Intentional stakeholder coordination will be needed for successful outcomes. CHAI remains committed to supporting countries, together with our partners, in this process.
For more information, please read the World Hepatitis Alliance short brief for advocates and watch the webinar discussing opportunities for countries to include hepatitis programming in their proposals here.
